in

Grøntvedt increases production of CETO3 omega-11

Introduced in 2023, CETO3 is sourced from North Atlantic Pelagic Fish and contains cetoleic acid, also known as omega-11. Early studies have found that omega-11 can stimulate the body’s production of EPA/DHA via the liver’s conversion of ALA to boost omega-3 index and omega-11 levels.

Studies with oils rich in omega-11 (cetoleic acid) have shown significant improvements in LDL cholesterol, insulin sensitivity and glucose levels,” said Stig Jansson, chief innovation officer at Grøntvedt Biotech. “These are areas where standard fish oil with EPA/DHA have shown low or no effects.”

The ingredient’s 30-minute processing time from fresh fish to oil reduces the risk of lipid oxidation and eliminates fishy smell or taste for incorporation into capsule or liquid products.

“We already have consumer product launches out in the global consumer market with innovative first mover consumer brands and more launches to come globally in 2024,” added Henrik Traaholt, the company’s chief commercial officer.

The investment will be used to boost production at Grøntvedt’s processing plant in Uthaug, Norway, increasing the availability of the new-to-market ingredient by 50% to meet fast-growing demand for omega-3 and alternative ingredients.

Sustainable sourcing

Grøntvedt uses pelagic fish, defined as fish that occupy midwater and upper layers of the ocean, and explains that “all pelagic fish is low on environmental pollutants as they swim neither close to the bottom or near the shore ensuring it is low on environmental pollutants.”

What do you think?

Written by The Muscle Mag

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Valensa promotes saw palmetto for hair growth

Cepham introduces Luteye, a powerful solution to combat eye aging and additives with the use of olive oil as a carrier